Mobile Contingency Management for Smoking Cessation
(P3 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people quit smoking by testing a new approach that combines standard care with mobile financial incentives. Participants can earn rewards through an automated system called Automated Mobile Contingency Management (CM), which uses mobile phones and carbon monoxide monitors to confirm they haven't smoked. This trial specifically targets individuals who smoke at least five cigarettes daily, have a low income, and are ready to quit soon. The goal is to determine if this method is effective and cost-efficient, potentially improving future smoking cessation programs. As an unphased trial, it offers participants the opportunity to contribute to innovative research that could enhance smoking cessation strategies.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, you must be willing to quit smoking and abstain from smoking cannabis and other tobacco products.
What prior data suggests that this mobile contingency management approach is safe for smoking cessation?
Research has shown that automated mobile systems to aid smoking cessation are generally well-received. Studies have found that providing financial rewards via mobile phones for not smoking can effectively support quitting. Importantly, these studies did not identify any serious safety issues. Participants used portable devices to verify their non-smoking status, and the technology proved safe.
This trial is in the "Not Applicable" phase, focusing on system functionality rather than safety testing. However, similar methods in past studies have not demonstrated any serious side effects, indicating a positive safety profile. The system complements standard care, such as phone counseling and nicotine patches, which are common and safe methods to assist smoking cessation.
In summary, the automated mobile system appears to be a safe method to help people quit smoking. It employs proven technology and methods without known serious risks.12345Why are researchers excited about this trial?
Researchers are excited about the Mobile Contingency Management (CM) for smoking cessation because it combines standard care with small financial incentives for quitting smoking, verified through biochemical tests. This approach is innovative because it adds a motivational component that rewards individuals for their progress, potentially enhancing their commitment to quitting. Unlike traditional methods, which often rely solely on counseling and medication, this technique leverages positive reinforcement, making the quitting process more engaging and encouraging.
What evidence suggests that this trial's treatments could be effective for smoking cessation?
Studies have shown that contingency management (CM), a treatment in this trial, can help people quit smoking by offering small financial rewards for remaining smoke-free. Research indicates this method is cost-effective, particularly for groups like homeless veterans. In this trial, some participants will receive CM combined with standard care, including counseling and nicotine patches, enhancing its effectiveness. Mobile technology offers a low-cost way to deliver this method, increasing accessibility. This approach has been tested in various groups and shows promise in helping them quit successfully.12678
Who Is on the Research Team?
Darla E. Kendzor, PhD
Principal Investigator
University of Oklahoma
Are You a Good Fit for This Trial?
This trial is for adults over 18 who smoke at least 5 cigarettes daily, want to quit within 7-14 days after joining, and earn below a certain income level. They must not use other tobacco products or have conditions that prevent using nicotine replacement therapy (NRT). A valid ID and U.S. residence proof are required.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either standard care with telephone counseling and nicotine replacement therapy or standard care plus a 12-week smartphone-based financial incentives intervention for smoking cessation
Follow-up
Participants are monitored for smoking abstinence and cost-effectiveness for 26 weeks after the scheduled quit attempt
What Are the Treatments Tested in This Trial?
Interventions
- Automated Mobile Contingency Management (CM)
- Standard Care (SC)
Automated Mobile Contingency Management (CM) is already approved in United States for the following indications:
- Smoking cessation
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Oklahoma
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
M.D. Anderson Cancer Center
Collaborator
H. Lee Moffitt Cancer Center and Research Institute
Collaborator
University of Florida
Collaborator